| Whole‐exome sequencing of pancreatic neoplasms with acinar differentiation Y Jiao, R Yonescu, GJA Offerhaus, DS Klimstra, A Maitra, JR Eshleman, ... The Journal of pathology 232 (4), 428-435, 2014 | 168 | 2014 |
| HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells SN Shah, L Cope, W Poh, A Belton, S Roy, CC Talbot Jr, S Sukumar, ... PloS one 8 (5), e63419, 2013 | 128 | 2013 |
| Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma W Poh, W Wong, H Ong, MO Aung, SG Lim, BT Chua, HK Ho Molecular cancer 11, 1-10, 2012 | 90 | 2012 |
| HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis A Schuldenfrei, A Belton, J Kowalski, CC Talbot, F Di Cello, W Poh, ... BMC genomics 12, 1-17, 2011 | 86 | 2011 |
| A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia I Gojo, JH Beumer, KW Pratz, MA McDevitt, MR Baer, AL Blackford, ... Clinical Cancer Research 23 (3), 697-706, 2017 | 69 | 2017 |
| Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells BT Chua, SJ Lim, SC Tham, WJ Poh, A Ullrich Molecular oncology 4 (4), 323-334, 2010 | 69 | 2010 |
| DREAMing: a simple and ultrasensitive method for assessing intratumor epigenetic heterogeneity directly from liquid biopsies TR Pisanic, P Athamanolap, W Poh, C Chen, A Hulbert, MV Brock, ... Nucleic acids research 43 (22), e154-e154, 2015 | 59 | 2015 |
| Rare germline variants in ATM are associated with chronic lymphocytic leukemia G Tiao, MR Improgo, S Kasar, W Poh, A Kamburov, DA Landau, E Tausch, ... Leukemia 31 (10), 2244-2247, 2017 | 34 | 2017 |
| Poly (ADP-ribose) polymerase inhibitor hypersensitivity in aggressive myeloproliferative neoplasms KW Pratz, BD Koh, AG Patel, KS Flatten, W Poh, JG Herman, R Dilley, ... Clinical Cancer Research 22 (15), 3894-3902, 2016 | 28 | 2016 |
| DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cells MZ Hossain, MA Healey, C Lee, W Poh, SR Yerram, K Patel, NS Azad, ... Oncotarget 4 (2), 298, 2013 | 24 | 2013 |
| BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid … W Poh, RL Dilley, AR Moliterno, JP Maciejewski, KW Pratz, MA McDevitt, ... Clinical Cancer Research 25 (8), 2513-2522, 2019 | 16 | 2019 |
| Poly (ADP-ribose) polymerase inhibitor CEP-8983 synergizes with bendamustine in chronic lymphocytic leukemia cells in vitro RL Dilley, W Poh, DE Gladstone, JG Herman, MM Showel, JE Karp, ... Leukemia research 38 (3), 411-417, 2014 | 13 | 2014 |
| A glioblastoma neurosphere line with alternative lengthening of telomeres CM Heaphy, KC Schreck, E Raabe, XG Mao, P An, Q Chu, W Poh, Y Jiao, ... Acta neuropathologica 126, 607-608, 2013 | 11 | 2013 |
| Genetic and epigenetic defects in DNA repair lead to synthetic lethality of poly (ADP-Ribose) polymerase (PARP) inhibitors in aggressive myeloproliferative disorders MA McDevitt, BD Koh, A Patel, AR Moliterno, W Poh, JG Herman, ... Blood 118 (21), 400, 2011 | 5 | 2011 |
| A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Leukemias I Gojo, JH Beumer, K Pratz, J Ji, L Wang, MA Rudek, MA McDevitt, ... Blood, The Journal of the American Society of Hematology 126 (23), 1361-1361, 2015 | 2 | 2015 |
| Epigenetic Silencing of BRCA1 Is Linked to Homologous Recombination Repair Defects and Elevated Mir-155 Expression in Myeloid Neoplasms W Poh, AR Moliterno, KW Pratz, I Gojo, MA McDevitt, JG Herman Blood 124 (21), 3525, 2014 | 2 | 2014 |
| Germline rare variant association analysis in chronic lymphocytic leukemia J Brown, G Tiao, S Kasar, MR Improgo, W Poh, A Kamburov, DA Landau, ... Leuk. Lymphoma 58, 126-128, 2017 | | 2017 |
| GERMLINE RARE VARIANT ASSOCIATION ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA G Tiao, MR Improgo, S Kasar, W Poh, A Kamburov, DA Landau, E Tausch, ... Haematologica 102, 65-66, 2017 | | 2017 |
| CONSEQUENCES OF BRCA1 EPIGENETIC SILENCING ON HOMOLOGOUS RECOMBINATION AND DISEASE PROGRESSION IN MYELOID NEOPLASMS W Poh Johns Hopkins University, 2015 | | 2015 |
| Pcft Is Silenced By DNA Methylation In Pediatric Acute Lymphoblastic Leukemia Resulting In Decreased Methotrexate Uptake CK Lee, W Poh, M Healey, ES Schafer, P Brown, JG Herman Blood 122 (21), 3768, 2013 | | 2013 |
Leslie CopeJohns Hopkins UniversityVerified email at jhmi.edu
